Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 25, 2023

BUY
$191.51 - $216.16 $1.15 Million - $1.3 Million
6,000 Added 21.66%
33,700 $7.15 Million
Q2 2023

Aug 03, 2023

SELL
$187.64 - $206.25 $93,820 - $103,125
-500 Reduced 1.77%
27,700 $5.33 Million
Q1 2023

Apr 21, 2023

SELL
$127.59 - $203.08 $688,986 - $1.1 Million
-5,400 Reduced 16.07%
28,200 $5.71 Million
Q4 2022

Feb 02, 2023

BUY
$117.37 - $139.17 $715,957 - $848,936
6,100 Added 22.18%
33,600 $4.32 Million
Q3 2022

Oct 17, 2022

BUY
$135.27 - $180.11 $94,689 - $126,077
700 Added 2.61%
27,500 $3.76 Million
Q2 2022

Aug 11, 2022

BUY
$108.81 - $179.33 $32,643 - $53,799
300 Added 1.13%
26,800 $4.74 Million
Q1 2022

May 09, 2022

SELL
$119.61 - $157.85 $251,181 - $331,485
-2,100 Reduced 7.34%
26,500 $3.82 Million
Q4 2021

Feb 11, 2022

BUY
$142.57 - $190.86 $128,313 - $171,774
900 Added 3.25%
28,600 $4.42 Million
Q3 2021

Nov 10, 2021

SELL
$142.45 - $169.82 $826,209 - $984,956
-5,800 Reduced 17.31%
27,700 $4.7 Million
Q2 2021

Aug 12, 2021

BUY
$135.08 - $161.1 $1.16 Million - $1.39 Million
8,600 Added 34.54%
33,500 $5.29 Million
Q1 2021

May 11, 2021

BUY
$137.51 - $190.8 $426,281 - $591,480
3,100 Added 14.22%
24,900 $3.46 Million
Q4 2020

Feb 09, 2021

BUY
$164.63 - $211.93 $3.59 Million - $4.62 Million
21,800 New
21,800 $3.82 Million

Others Institutions Holding SGEN

About Seagen Inc.


  • Ticker SGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,664,992
  • Description
  • Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...
More about SGEN
Track This Portfolio

Track Forsta Ap Fonden Portfolio

Follow Forsta Ap Fonden and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

News

Stay updated on Forsta Ap Fonden with notifications on news.